Stay updated on Radiation Doses for Immunotherapy Progression Clinical Trial
Sign up to get notified when there's something new on the Radiation Doses for Immunotherapy Progression Clinical Trial page.

Latest updates to the Radiation Doses for Immunotherapy Progression Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check39 days agoChange DetectedThe webpage has undergone significant updates, including the addition of a new open label Phase 2 screening trial for metastatic cancers and the removal of detailed information about checkpoint inhibitors and their combination with radiation therapy.SummaryDifference41%
- Check46 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check82 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check104 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check111 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Radiation Doses for Immunotherapy Progression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiation Doses for Immunotherapy Progression Clinical Trial page.